NSE · MOREPENLAB
Morepen Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#743
of 5,072 stocks
▼ 91W
Peak #734 · 21 Sep 2026
A midcap name in Healthcare, Morepen Laboratories Limited carries a steep earnings multiple that prices in strong future growth, is seeing revenue slip, and posts a modest return on equity.
Market Cap
6,595.87 Cr
P/E Ratio
69.58
P/B Ratio
5.29
ROE
7.61%
ROCE
7.64%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 570.13 Cr | 484.72 Cr | 484.16 Cr | 411.58 Cr |
| Net Profit | 56.40 Cr | 15.74 Cr | 27.51 Cr | 40.87 Cr |
| EPS | 1.03 | 0.28 | 0.50 | 0.75 |
| Operating Profit | 79.37 Cr | 27.16 Cr | 39.74 Cr | 24.05 Cr |
Shareholding pattern
Promoter
35.65%
Public
64.35%
Mutual fund holdings
₹0.09
Cr total
3
Schemes
2
Fund Houses
₹0.09 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.06 Cr (67.4%)
Bandhan Mutual Fund₹0.03 Cr (32.6%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Sep 2026 | Dividend | Dividend - Re 0.20 Per Share |
| 29 Aug 2025 | Dividend | Dividend - Re 0.20 Per Share |
| 20 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 19 Sep 2022 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.